Jeremy Schneider is a Dermatology physician affiliated with University of California San Diego. OpenAlex indexes 13 publications with 316 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- LEO Pharma Inc.Program year20241 payment
- ABBVIE INC.Program year20241 payment
- ViiV Healthcare CompanyProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
59.7%Azole Antifungal43.8%Ketoconazole100%Part D≥34 patientsLincosamide Antibacterial16%Clindamycin Phosphate100%Part D<11 patientsDermatology
12.5%Corticosteroid12.5%Triamcinolone Acetonide100%Part D<11 patientsCancer & immunology
10.4%Nucleoside Metabolic Inhibitor10.4%Fluorouracil100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pharmacogenomics of Allopurinol and Sulfamethoxazole/Trimethoprim: Case Series and Review of the Literature
Journal of Personalized Medicine
2021 - 26775 Vancomycin-associated drug-induced hypersensitivity syndrome after IV therapy with vancomycin and implantation of a vancomycin-eluting spacer and absorbable beads
Journal of the American Academy of Dermatology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Eliezer Masliah, MD
University of California San Diego
Douglas Richman, MD
University of California San Diego
Robert Weinreb, MD
University of California San Diego
Irene Litvan, MD
University of California San Diego
Bridget Grant, MD
Bassett Medical Center
Robert Modlin, MD
University of California, Los Angeles
Andrew Blauvelt, MD
University of Maryland School of Medicine
Howard Maibach, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”